Skip to main content

Milestone in cryogenic engine test paves way for GSLV-MkIII (thehindu)

 A milestone crossed in the making of a new cryogenic rocket engine set the stage for the first flight of the country’s most powerful satellite launcher to date, the GSLV-Mark III. The cryogenic stage and the entire launch vehicle’s readiness is closer to fruition after the engine, technically called CE20, passed the ‘high altitude flight acceptance test’ lasting about 25 seconds at Mahendragiri in mid-December.

The Indian Space Research Organisation (ISRO) plans to fly its new launch vehicle powered by this new engine around March, and send the 3,200 kg GSAT-19 communication satellite to space on it. The launch was earlier slated for December 2016. MkIII, when it completes trials and commences functioning in the coming years, will double ISRO’s lifting power for communications satellites to 4,000 kilos.

Vital stage

In a few days from now, the rocket’s complete cryogenic third stage, replete with fuel tanks and systems built around the engine, will undergo its qualifying test, S. Somanath, Director of ISRO’s Liquid Propulsion Systems Centre (LPSC), Thiruvananthapuram, told The Hindu .

LPSC has designed and developed the CE20 engine. We are assembling the entire cryogenic stage, which is ready for flight. It will be sent to Sriharikota in a month’s time,” he said.

The cryogenic stage is vital for a GSLV rocket as it gets its final and biggest push in space from this stage; it can take a big communications satellite to higher reaches of 36,000 km above ground. The C25 cryogenic stage was approved at an estimated Rs. 600 crore as part of the overall Rs. 2,500-crore MkIII launcher project.

“Realising the CE20 engine was our target in order to achieve India’s capability to lift a four-tonne satellite to GTO (geostationary transfer orbit, around 36,000 km high),” Mr. Somanath said.

“We have been longing for this for a few years. MkIII will be the future work horse after the PSLV,” he said.

Comments

Popular posts from this blog

NGT terminates chairmen of pollution control boards in 10 states (downtoearth,)

Cracking the whip on 10 State Pollution Control Boards (SPCBs) for ad-hoc appointments, the National Green Tribunal has ordered the termination of Chairpersons of these regulatory authorities. The concerned states are Himachal Pradesh, Sikkim, Tamil Nadu, Uttarakhand, Kerala, Rajasthan, Telangana, Haryana, Maharashtra and Manipur. The order was given last week by the principal bench of the NGT, chaired by Justice Swatanter Kumar. The recent order of June 8, 2017, comes as a follow-up to an NGT judgment given in August 2016. In that judgment, the NGT had issued directions on appointments of Chairmen and Member Secretaries of the SPCBs, emphasising on crucial roles they have in pollution control and abatement. It then specified required qualifications as well as tenure of the authorities. States were required to act on the orders within three months and frame Rules for appointment [See Box: Highlights of the NGT judgment of 2016 on criteria for SPCB chairperson appointment]. Having

High dose of Vitamin C and B3 can kill colon cancer cells: study (downtoearth)

In a first, a team of researchers has found that high doses of Vitamin C and niacin or Vitamin B3 can kill cancer stem cells. A study published in Cell Biology International showed the opposing effects of low and high dose of vitamin C and vitamin B3 on colon cancer stem cells. Led by Bipasha Bose and Sudheer Shenoy, the team found that while low doses (5-25 micromolar) of Vitamin C and B3 proliferate colon cancer stem cells, high doses (100 to 1,000 micromolar) killed cancer stem cells. Such high doses of vitamins can only be achieved through intravenous injections in colon cancer patients. The third leading cause of cancer deaths worldwide, colon cancer can be prevented by an intake of dietary fibre and lifestyle changes. While the next step of the researchers is to delineate the mechanisms involved in such opposing effects, they also hope to establish a therapeutic dose of Vitamin C and B3 for colon cancer stem cell therapy. “If the therapeutic dose gets validated under in vivo

SC asks Centre to strike a balance on Rohingya issue (.hindu)

Supreme Court orally indicates that the government should not deport Rohingya “now” as the Centre prevails over it to not record any such views in its formal order, citing “international ramifications”. The Supreme Court on Friday came close to ordering the government not to deport the Rohingya. It finally settled on merely observing that a balance should be struck between humanitarian concern for the community and the country's national security and economic interests. The court was hearing a bunch of petitions, one filed by persons within the Rohingya community, against a proposed move to deport over 40,000 Rohingya refugees. A three-judge Bench, led by Chief Justice of India Dipak Misra, began by orally indicating that the government should not deport Rohingya “now”, but the government prevailed on the court to not pass any formal order, citing “international ramifications”. With this, the status quo continues even though the court gave the community liberty to approach i